NCT03440034View on ClinicalTrials.gov

Study of Pioglitazone in Sporadic Inclusion Body Myositis

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
MyositisInclusion Body MyositisMuscular DiseasesMusculoskeletal DiseaseNeuromuscular DiseasesNervous System Diseases
Interventions
DRUG

Pioglitazone

Pioglitazone comes as a tablet to take by mouth and can be taken with or without food.

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03440034 - Study of Pioglitazone in Sporadic Inclusion Body Myositis | Biotech Hunter | Biotech Hunter